Candelanza, Jessa Mae G.
HRN: 21-72-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/07/2025
CEFTRIAXONE 1G (VIAL)
10/07/2025
10/13/2025
IVT
750mg
Q24
AGE With Severe Dehydration
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalDisseminated Systemic Infection Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes